Literature DB >> 11768619

Detection of keyhole limpet hemocyanin (KLH)-specific immune responses by intracellular cytokine assay in patients vaccinated with idiotype-KLH vaccine.

S S Neelapu1, S Baskar, L W Kwak.   

Abstract

Keyhole limpet hemocyanin (KLH) has been used as an immune potentiator to enhance antigen-specific responses against haptens and weak antigens including self-antigens. In the present study, we describe the optimization of the intracellular cytokine response to KLH in peripheral blood mononuclear cells (PBMC) of lymphoma and myeloma patients that were vaccinated with tumor-specific immunoglobulin (Id) conjugated to KLH. Addition of anti-CD28 antibody significantly enhanced cytokine-producing CD4-T cells. While fresh PBMC showed maximal cytokine response 14 h after antigen stimulation, the frozen PBMC showed maximal cytokine responses by 24 h. Supplementation of the culture medium with fetal bovine serum gave a better signal-to-noise ratio than human AB serum in the intracellular detection of cytokines. The intracellular cytokine responses correlated with the cytokine measurements by enzyme-linked immunosorbent assay (ELISA). Together these results indicate that the intracellular cytokine assay is very helpful to measure antigen-specific immune responses, and in subsequent studies, we have utilized this sensitive technique to detect immune responses against tumor antigens such as idiotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11768619     DOI: 10.1007/bf01470994

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  3 in total

1.  Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.

Authors:  Seema Rawal; Fuliang Chu; Min Zhang; Hyun Jun Park; Durga Nattamai; Shibichakravarthy Kannan; Rakesh Sharma; David Delgado; Tina Chou; Heather Y Lin; Veerabhadran Baladandayuthapani; Amber Luong; Francisco Vega; Nathan Fowler; Chen Dong; R Eric Davis; Sattva S Neelapu
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

Review 2.  Biological response modifiers in cancer.

Authors:  Purabi Reang; Madhur Gupta; Kamlesh Kohli
Journal:  MedGenMed       Date:  2006-11-14

3.  Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters.

Authors:  Erik H J G Aarntzen; I Jolanda M de Vries; Joop H Göertz; Marjo Beldhuis-Valkis; Huberdina M L M Brouwers; Mandy W M M van de Rakt; Renate G van der Molen; Cornelis J A Punt; Gosse J Adema; Paul J Tacken; Irma Joosten; Joannes F M Jacobs
Journal:  Cancer Immunol Immunother       Date:  2012-04-21       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.